IPAD-DB ID | S01231 |
Name | Butyl caffeate |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 3 H 1 6 O 4 |
Molecular Weight | 236.26 g/mol |
IUPAC Name | butyl(E)-3-(3, 4-dihydroxyphenyl)prop-2-enoate |
InChI | InChI=1S/C13H16O4/c1-2-3-8-17-13(16)7-5-10-4-6-11(14)12(15)9-10/h4-7, 9, 14-15H, 2-3, 8H2, 1H3/b7-5+ |
InChIKey | DBBCBZIFZYILRL-FNORWQNLSA-N |
Canonical SMILES | CCCCOC(=O)C=CC1=CC(=C(C=C1)O)O |
PubChem CID | 9991705 |
DrugBank Accession Number | - |
CAS Registry Number | 22020-28-6 |
Molecular Weight(Computed by SwissADME) | 236.26 |
Hac(Computed by SwissADME) | 17 |
Volume(Computed by ADMETlab 2.0) | 246.826 |
Density(Computed by ADMETlab 2.0) | 0.957 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 8 |
Flexibility(Computed by ADMETlab 2.0) | 0.75 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -2.631 |
LogD(Computed by ADMETlab 2.0) | 3.027 |
logP(Computed by ADMETlab 2.0) | 3.128 |
TPSA(Computed by SwissADME) | 66.76 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 6 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.23 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |